Recombinant Human Antibody is capable of binding to S. aureus LPA, expressed in HEK 293 cells. Expressed as the combination of a heavy chain (HC) containing VH from anti-S. aureus LPA mAb and CH1-3 region of human IgG1 and a light chain (LC) encoding VL from anti-S. aureus LPA mAb and CL of human kappa light chain. Exists as a disulfide linked dimer of the HC and LC hetero-dimer under non-reducing condition.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
PSBL-329 | Recombinant Human Anti-S. aureus LPA Antibody scFv Fragment | WB, ELISA, FuncS | scFv |
HPAB-0253-YC-S(P) | Mouse Anti-LPA Recombinant Antibody (clone 2D1); scFv Fragment | ELISA, WB | Mouse scFv |
HPAB-0254-YC-S(P) | Mouse Anti-LPA Recombinant Antibody (clone B3); scFv Fragment | ELISA, FuncS | Mouse scFv |
HPAB-0255-YC-S(P) | Human Anti-LPA Recombinant Antibody (clone hB3); scFv Fragment | ELISA, FuncS | Humanized scFv |
HPAB-1295-FY-F(E) | Human Anti-LPA Recombinant Antibody (clone B7); scFv Fragment | ELISA | Humanized scFv |
There are currently no Customer reviews or questions for PABL-329. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.